Physician profile
Timothy Thomas
NPI 1023122124
$2,421.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2020: $97.85 · 2021: $454 · 2022: $246 · 2023: $51.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,056.20 | 2019 | |
| Stryker Corporation | $499.62 | 2020-2023 | Augment Injectable, Variax, Actishield Cf |
| Depuy Synthes Sales INC. | $349.87 | 2019 | |
| Smith+Nephew, INC. | $189.77 | 2019-2022 | |
| Anika Therapeutics, INC. | $95.06 | 2022 | |
| Virtus Pharmaceuticals LLC | $53.03 | 2021 | |
| Ibsa Pharma INC. | $27.76 | 2021 | |
| Bioventus LLC | $26.75 | 2020-2021 | |
| Acera Surgical, INC. | $24.79 | 2023 | Restrata Wound Matrix |
| Medtronic, INC. | $21.18 | 2022 | |
| Nalu Medical, INC. | $21.04 | 2022 | |
| Grt US Holding, INC. | $14.33 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.27 | 2019 | |
| Orthofix Medical, INC. | $14.08 | 2021 | |
| Almatica Pharma LLC | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.